DSM Venturing and Strategic Health Investment Partners extended the Stanford cartilage replacement spinout's series A round, augmenting a $16m first close featuring Johnson & Johnson and Osage University Partners.

Chicago’s endowment participated in the series A, following a $1.1m seed round last year that included prize money from the Chicago-run New Venture Challenge.

HTGF has returned to back Freiburg's single cell-dispensing spinout Cytena after previously featuring in the company’s $1.3m round in 2015.

Building on work at MIT’s Koch Institute of Integrative Cancer Research, Elicio hopes to begin patient studies in 2020 for pancreatic, colorectal, head and neck cancers.

Sofinnova Partners and New Enterprise Associates have co-led an oversubscribed series A round for Polyneuron Pharmaceuticals, spun out of University of Basel.

TU Berlin spinout IPlytics has collected several million dollars from investors including High-Tech Gründerfonds to expand into the US, South Korea and Japan.

Sherlock Biosciences will develop molecular diagnostics tools co-developed by researchers at Harvard University and Broad Institute, including Crispr inventor Feng Zhang.

The series A funding comes after predictive data analytics companies MoBagel went through a resources-only edition of the SkyDeck accelerator last year.

Utec joined Dentsu in the fine art providence blockchain creator’s latest round, after supplying $900,000 of seed capital in July 2018.

Cystic fibrosis drug developer Respirion Pharmaceuticals has spun out from Telethon Kids Institute with capital from an Australian government-backed initiative.